Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.56NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.29NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.112NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.123NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.143NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.29NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.48NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.46.6.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.112.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.360NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.347NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.195NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.321NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.379NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.78NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.16NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.231NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.49NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.67NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.190NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.120NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AM.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AA.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.249NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AA.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.505NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.406NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.115NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.29NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AA.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FS.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.54NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.29NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.29NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
N.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.15 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.348NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.575NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.26NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Q.4 (Alpha)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.442NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.1 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.2.5.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.600NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.12 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.525 (Eta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.6 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.5.5 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.7 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used